☰

Gregory C. Sartor - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
addiction
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

16/28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Singh MB, Babigian CJ, Sartor GC. Domain-selective BET inhibition attenuates transcriptional and behavioral responses to cocaine. Neuropharmacology. 210: 109040. PMID 35314160 DOI: 10.1016/j.neuropharm.2022.109040  0.459
2018 Sartor GC, Malvezzi AM, Kumar A, Andrade NS, Wiedner HJ, Vilca SJ, Janczura KJ, Bagheri A, Al-Ali H, Powell SK, Brown PT, Volmar CH, Foster TC, Zeier Z, Wahlestedt C. Enhancement of BDNF expression and memory by HDAC inhibition requires BET bromodomain reader proteins. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30504275 DOI: 10.1523/Jneurosci.1604-18.2018  0.321
2018 Zhu W, Wang H, Wei J, Sartor GC, Bao MM, Pierce CT, Wahlestedt CR, Dykxhoorn DM, Dong C. Cocaine Exposure Increases Blood Pressure and Aortic Stiffness via the miR-30c-5p-Malic Enzyme 1-Reactive Oxygen Species Pathway. Hypertension (Dallas, Tex. : 1979). PMID 29483230 DOI: 10.1161/Hypertensionaha.117.10213  0.434
2017 Sartor GC, Powell SK, Velmeshev D, Lin DY, Magistri M, Wiedner HJ, Malvezzi AM, Andrade NS, Faghihi MA, Wahlestedt C. Cocaine alters Homer1 natural antisense transcript in the nucleus accumbens. Molecular and Cellular Neurosciences. PMID 29055697 DOI: 10.1016/J.Mcn.2017.10.003  0.477
2015 Sartor GC, Powell SK, Wiedner HJ, Wahlestedt C, Brothers SP. "Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice". Brain Research. PMID 26657743 DOI: 10.1016/J.Brainres.2015.11.044  0.535
2015 Sartor GC, Powell SK, Brothers SP, Wahlestedt C. Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 15062-72. PMID 26558777 DOI: 10.1523/Jneurosci.0826-15.2015  0.553
2014 Sartor GC, Aston-Jones G. Post-retrieval extinction attenuates cocaine memories. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1059-65. PMID 24257156 DOI: 10.1038/Npp.2013.323  0.622
2013 Aston-Jones G, Mahler S, Sartor G, Smith R, Moorman D. Seeking reward: Upstream modulation of VTA dopamine neurons by orexin/hypocretin inputs Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 173-174. DOI: 10.1016/B978-0-12-800044-1.00153-7  0.71
2012 Sartor GC, Aston-Jones G. Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference. The European Journal of Neuroscience. 36: 3549-58. PMID 23039920 DOI: 10.1111/J.1460-9568.2012.08277.X  0.705
2012 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Progress in Brain Research. 198: 79-121. PMID 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0  0.708
2012 Sartor GC, St Laurent G, Wahlestedt C. The Emerging Role of Non-Coding RNAs in Drug Addiction. Frontiers in Genetics. 3: 106. PMID 22737160 DOI: 10.3389/Fgene.2012.00106  0.39
2012 Sartor GC, Aston-Jones GS. A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 4623-31. PMID 22457508 DOI: 10.1523/Jneurosci.4561-11.2012  0.712
2012 Reissner KJ, Sartor GC, Vazey EM, Dunn TE, Aston-Jones G, Kalivas PW. Use of vivo-morpholinos for control of protein expression in the adult rat brain. Journal of Neuroscience Methods. 203: 354-60. PMID 22027492 DOI: 10.1016/J.Jneumeth.2011.10.009  0.662
2011 McGinty VB, Hayden BY, Heilbronner SR, Dumont EC, Graves SM, Mirrione MM, du Hoffmann J, Sartor GC, España RA, Millan EZ, Difeliceantonio AG, Marchant NJ, Napier TC, Root DH, Borgland SL, et al. Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference. Behavioural Brain Research. 225: 348-57. PMID 21816177 DOI: 10.1016/J.Bbr.2011.07.036  0.376
2010 Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiology & Behavior. 100: 419-28. PMID 20338186 DOI: 10.1016/J.Physbeh.2010.03.009  0.712
2010 Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Research. 1314: 74-90. PMID 19815001 DOI: 10.1016/J.Brainres.2009.09.106  0.721
Low-probability matches (unlikely to be authored by this person)
2019 Sartor GC. Epigenetic pharmacotherapy for substance use disorder. Biochemical Pharmacology. PMID 31306644 DOI: 10.1016/j.bcp.2019.07.012  0.287
2017 Volmar CH, Salah-Uddin H, Janczura KJ, Halley P, Lambert G, Wodrich A, Manoah S, Patel NH, Sartor GC, Mehta N, Miles NTH, Desse S, Dorcius D, Cameron MD, Brothers SP, et al. M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory. Proceedings of the National Academy of Sciences of the United States of America. 114: E9135-E9144. PMID 29073110 DOI: 10.1073/Pnas.1707544114  0.276
2018 Janczura KJ, Volmar CH, Sartor GC, Rao SJ, Ricciardi NR, Lambert G, Brothers SP, Wahlestedt C. Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model. Proceedings of the National Academy of Sciences of the United States of America. PMID 30397132 DOI: 10.1073/Pnas.1805436115  0.271
2016 Aziz AM, Brothers S, Sartor G, Holm L, Heilig M, Wahlestedt C, Thorsell A. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models. Psychopharmacology. PMID 27515665 DOI: 10.1016/J.Alcohol.2017.02.313  0.26
2016 Magistri M, Velmeshev D, Makhmutova M, Patel P, Sartor GC, Volmar CH, Wahlestedt C, Faghihi MA. The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer's disease. Current Alzheimer Research. PMID 27117003 DOI: 10.2174/1567205013666160427101832  0.228
2018 Volmar C, Salah-Uddin H, Janczura KJ, Halley P, Lambert G, Wodrich A, Manoah S, Patel NH, Sartor GC, Mehta N, Miles NT, Desse S, Dorcius D, Cameron MD, Brothers SP, et al. 112. Multipronged HDAC Strategy for Alzheimer’s Disease Biological Psychiatry. 83: S46. DOI: 10.1016/J.Biopsych.2018.02.130  0.21
2006 Volmar C, Janczura KJ, Lambert G, Salah-Uddin H, Halley P, Sartor GC, Brothers SP, Wahlestedt C. P4-220: MULTIFACTORIAL EPIGENETIC STRATEGY FOR ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1527-P1527. DOI: 10.1016/J.Jalz.2018.07.041  0.199
2020 Singh MB, Sartor GC. BET bromodomains as novel epigenetic targets for brain health and disease. Neuropharmacology. 181: 108306. PMID 32946883 DOI: 10.1016/j.neuropharm.2020.108306  0.163
2022 Seyednejad SA, Sartor GC. Noncoding RNA therapeutics for substance use disorder. Advances in Drug and Alcohol Research. 2. PMID 36601439 DOI: 10.3389/adar.2022.10807  0.146
2022 Kasina V, Mownn RJ, Bahal R, Sartor GC. Nanoparticle delivery systems for substance use disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35351961 DOI: 10.1038/s41386-022-01311-7  0.143
2023 Drinkuth CR, Lehane MJ, Sartor GC. The effects of (2R,6R)-hydroxynorketamine on oxycodone withdrawal and reinstatement. Drug and Alcohol Dependence. 253: 110987. PMID 37864957 DOI: 10.1016/j.drugalcdep.2023.110987  0.136
2017 Aziz AMA, Brothers S, Sartor G, Heilig M, Wahlestedt C, Thorsell A. The Nociceptin/Orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: Validation in rat models Alcohol. 60: 233. DOI: 10.1016/J.ALCOHOL.2017.02.313  0.081
Hide low-probability matches.